Menu Back to DIA-Global-Clinical-Trial-Disclosure-and-Data-Transparency-Conference


If you are looking for an opportunity to stay informed on the latest developments in clinical trial disclosure and data transparency from the comfort of your own home or office, the upcoming Clinical Trial Disclosure and Data Transparency Virtual Conference is a meeting you won't want to miss. This virtual conference builds on the success of prior editions, leveraging insights from regulatory bodies and industry experts from around the world.

By attending, you will gain essential and timely information on global clinical trial disclosure, data sharing for secondary research, and the EU Clinical Trial Information System (CTIS), all from the convenience of your computer or mobile device. For those in R&D management, Clinical Development, Out Licensing and Merger & Acquisitions: understanding the requirements and rules around CCI disclosure and protection under EU CTR is key to mitigate potential risks relating to portfolio assets.

With a focus on transparency while protecting personal data and commercially confidential information, this conference is a must-attend for anyone involved in clinical trials.





Want to learn more about DIA Global Clinical Trial Disclosure and Data Transparency Conference ? You've come to the right site!


Learn more

Who should attend?

Professionals from Industry, Academia, Regulatory Authorities and other domain involved in:

  • Clinical Trial Disclosure
  • Data Transparency/Data Sharing
  • Transparency Policies and Compliance
  • CTIS specialists and key users
  • Medical Writing, Medical Affairs, and Medical Communications
  • Clinical Operations
  • Compliance/Legal
  • Clinical Data Protection
  • Regulatory
  • Publications
  • Data Management
  • Clinical/Medical Research
  • Patient Advocacy


Get a sneak peek at DIA Global Clinical Trial Disclosure and Data Transparency Conference with these 2 free sessions from last year's conference! 

EU CTR: Transparency, PPD, and CCI Requirements

Hear about the strategic view of achieving transparency and the utility of data in CTIS while ensuring EU remains attractive for clinical trials by ensuring sponsors commercially confidential information is protected.

Watch Now

CTIS/CTR: 1 Year into its full Application

What have been the experiences with the CTIS and CTR after 1 year of its application, from different stakeholders: from sponsors to regulators and national competent authorities?

Watch Now

Program Committee

  • Merete  Joergensen, MBA, MSc
    Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
    Merete-J Consulting CVR: 34920818, Denmark
  • Scott  Feiner
    Scott Feiner Senior Manager, Clinical Records Management, Strategic Clinical Operations
    AbbVie, United States
  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
  • Matthias  Zerm, PhD
    Matthias Zerm, PhD Lead Expert, Clinical Trial Disclosure and R&D Processes
    Merz Therapeutics Gmbh, Germany
  • Thomas  Schindler, PhD
    Thomas Schindler, PhD Director Global Regulatory Affairs - Regulatory Operations
    BioNTech SE, Germany
  • Joyce  Swart
    Joyce Swart Clinical Disclosure Lead
    Alcon Research, LLC, United States
  • Lora  Killian, MBA
    Lora Killian, MBA Clinical Trial Transparency and Disclosure Lead
    Pfizer Inc, United States
  • Ruediger  Pankow, DrSc
    Ruediger Pankow, DrSc Regulatory Affairs Expert, CTIS Project Owner
Load More

Contact us

Registration Questions

Send Email
+41 61 225 51 51

Agenda and Logistics

Send Email
+41 61 225 51 51

Digital Learning Catalog

DIA Learning: eLearning Soultions